# Apellis Pharmaceuticals

**Type:** Funders  
**Canonical URL:** https://scholariq.org/funders/apellis-pharmaceuticals/

## Facts

| Field | Value |
| --- | --- |
| Country | US |
| Description | company in Crestwood, United States |
| OpenAlex ID | https://openalex.org/F4320319069 |
| ROR ID | https://ror.org/0231n7e68 |
| Works | 746 |

## Funder papers

- [Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases](https://scholariq.org/papers/executive-summary-of-the-kdigo-2021-guideline-for-the-management-of-glomerular/)
- [Real-World Patient Characteristics, Burden, and Quality of Life in C3 Glomerulopathy and Primary Immune Complex Membranoproliferative GN](https://scholariq.org/papers/real-world-patient-characteristics-burden-and-quality-of-life-in-c3/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.